Scholars Central

Conference abstractPublished 19 Oct 2017

Homology modeling, docking, synthesis and pharmacological evaluation of new chromen-2-one derivatives with atypical antipsychotic activity

Authors: Ashish A. Gawai, Sanjib Das, Pratap Parida, K. Biyani

Dept. of Pharma. Chemistry, Anuradha College of Pharmacy, India; Dept. of Pharmacology, Assam University, Silchar, India; Center for Biotechnology and Bioinformatics, Dibrugarh University, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: Schizophrenia is a chronic mental illness commonly with hallucinations, delusions, disorganized speech and disorganized thinking. Schizophrenia is a complex disorder whose etiology and pathogenesis is not completely understood. Schizophrenia is associated with the increased activity of dopaminergic and serotoninergic receptor sites. The purpose of this work is to discover new derivatives by homology modeling, design, synthesis and preliminary pharmacological studies of synthesized compounds with minimum side effects and better pharmacological action. Methodology & Theoretical Orientation: A Homology modeling and simulation was carried out by using Modellar 9v8 software followed by template identification and its alignment with target structure. The analysis of protein receptor structures for Dopamine (D2) and Serotonin (5HT2A) receptors and validation was performed on Exome Horizon 1.3 software. Docking studies were performed on same software and some selected active chromen-2-one derivatives were synthesized (B4a-B4k). Preliminary pharmacological screening such as Apomorphine induced climbing behavior i.e predictive of Dopaminergic (D2) antagonistic activity and 5HTP induced head twitches i.e predictive of serotonergic (5-HT) antagonistic activity were performed. Support of docking and preliminary pharmacological results gives lead for identification of final active molecules. Conclusion & Significance: All the synthesized compounds possessed dopaminergic antagonist and also possessed significant antagonistic activity at serotonin (5-HT) receptor (5HTP induced head twitches) which is an index of hypothesized atypical antipsychotic profile. The compounds which were substituted with Chloro ortho and Meta position showed significant dopamine D2 receptor antagonistic activity & the compounds which were substituted with Chloro at ortho position and Chloro and Fluoro at Meta position showed significant 5HT receptor antagonistic activity. From this data, we can conclude that compound (B4e) has better atypical antipsychotic profile. Recent Publications 1.Sandhya K (2011) Interaction of novel hybrid compounds with the D3 dopamine receptor: site-directed mutagenesis and homology modeling studies. Biochem Pharmcol 81:157- 163. 2.Morris G (1998) Automated Docking Using a Lamarckian Genetic Algorithm and Empirical Binding Free Energy Function. J Comput Chem 19:1639-1662. 3.Hrib NJ (1994) Benzisoxazole and Benzisothiazole-3- carboxamides as potential atypical antipsychotic agents. J Med Chem 37: 2308-2314. 4.Davis AS (1986) A comparison of motor behaviours in groups of rats distinguished by their climbing response to apomorphine. Br J Pharmacol 87:1:129-137 5.Chung WJ (2002) Behavioural pharmacology of polygalasaponins indicates potential antipsychotic efficacy. Pharmacol Biochem Behav 71:191-195.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDrug Designing: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Ashish A. Gawai”
  • BylineArticles whose byline prints “Sanjib Das”
  • BylineArticles whose byline prints “Pratap Parida”
  • BylineArticles whose byline prints “K. Biyani”